QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report “(S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran was estimated to be worth US$ 17.81 million in 2025 and is projected to reach US$ 92.92 million, growing at a CAGR of 25.7% from 2026 to 2032.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6456138/s–3–4–5-bromo-2-chlorobenzyl-phenoxy-tetrahydrofuran
Product Overview and Scope of (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran
CAS: 915095-89-5. (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran (English name: (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran) is a chiral organic compound classified as a derivative of tetrahydrofuran. (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran serves as a crucial pharmaceutical intermediate, specifically utilized in the synthesis of SGLT-2 inhibitor-class antidiabetic medications (particularly Empagliflozin). Although it incorporates a tetrahydrofuran ring structure, it is by no means the solvent THF; rather, it is a highly functionalized chiral synthetic building block that plays an indispensable role in the production of diabetes treatment drugs.
This intermediate is a key chiral intermediate within the synthesis pathway of the SGLT-2 inhibitor Empagliflozin (trade name: Jardiance), bearing the CAS number 915095-89-5. As this product is a pharmaceutical intermediate rather than a final consumer product, publicly available independent market data are relatively limited; consequently, its market size and competitive landscape are primarily driven by the market performance of downstream SGLT-2 inhibitor end-products, such as Empagliflozin.
In terms of the supplier landscape, dozens of domestic enterprises are currently registered as suppliers of this intermediate. While industry competition is relatively intense, the market has not yet reached a state of high concentration. Representative companies in this sector include Nanjing Weikaier, Hongyuan Pharmaceutical, Sanyuan Pharmaceutical, and Shenzhen Shangnuo Biotechnology, among others. Some of these enterprises have successfully completed vertical integration—spanning from intermediate production to Active Pharmaceutical Ingredient (API) manufacturing—thereby securing integrated cost advantages. Regarding sales channels, for some companies, export sales account for as much as 80% of their total volume, with primary markets including Europe, the Americas, Japan, and South Korea. Furthermore, some companies are expanding their market presence through a hybrid model: combining direct sales with distribution for upstream molecular building blocks, while selling downstream APIs and intermediates directly to pharmaceutical enterprises.
In terms of production models, the industry exhibits a landscape where outsourced manufacturing—specifically CMO and CDMO services—coexists with in-house production. Some companies have implemented technological upgrades to achieve flexible manufacturing, enabling them to switch production on a single line to manufacture a variety of intermediates, such as (S)-3-hydroxytetrahydrofuran. This model facilitates the full utilization of production capacity and mitigates the risks associated with fluctuations in demand for a single product; it represents one of the key trends within the industry’s midstream segment.
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran Market Summary
According to the new market research report “Global (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran Market Report 2026-2032”, published by QYResearch, the global (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran market size is projected to reach USD 0.04 billion by 2032, at a CAGR of 25.7% during the forecast period.
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran market is segmented as below:
By Company
Zhejiang HongYuan Pharmaceutical Co., Ltd.（CN）
Jiangxi Sanyuan Pharmaceutical Co., Ltd.（CN）
Aarti Pharmalabs（IN）
Senova Technology Co., Ltd.（CN）
Nanjing Weikaier Biomedical Technology Co., Ltd.（CN）
Anqing Chico Pharmaceutical Co., Ltd.（CN）
Menovo（CN）
Huateng Pharma（CN）
Bakul Pharma（IN）
Jay Finechem Private Limited（IN）
Segment by Type
Purity 97%
Purity 98%
Purity 99%
Segment by Application
Pharmaceutical Synthesis Intermediate
Other
Each chapter of the report provides detailed information for readers to further understand the (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran market:
Chapter 1: Introduces the report scope of the (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.
Other relevant reports of QYResearch:
Global (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran Market Outlook, In‑Depth Analysis & Forecast to 2032
Global (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global (S)-3-(4-(5-Bromo-2-Chlorobenzyl)Phenoxy)Tetrahydrofuran Market Research Report 2026
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
